EXHIBIT
31.2





CERTIFICATION
OF VICE PRESIDENT OF CORPORATE FINANCE PURSUANT TO


SECTION
302(a) OF THE SARBANES-OXLEY ACT OF 2002





I,
Yongqiang Wang, certify that:





1. I have
reviewed this quarterly report on Form 10-Q of Shengtai Pharmaceutical,
Inc.





2. Based on my
knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light
of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report;





3. Based on my
knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the
periods presented in this report;





4. The
registrant’s other certifying officer and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the registrant and have:


a) designed such
disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this report is being prepared; and


b) designed such
internal controls over financial reporting, or caused such internal controls
over financial reporting to be designed under our supervision, to provide
reasonable assurances regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles; and


c) evaluated the
effectiveness of the registrant’s disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and


d) disclosed in
this report any change in the registrant’s internal controls over financial
reporting that occurred during the registrant’s fiscal quarter ended September
30, 2009, that has materially affected or is reasonably likely to materially
affect the registrant’s internal controls over financial reporting.





5. The
registrant’s other certifying officer and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the
registrant’s auditors and the audit committee of registrant’s board of directors
(or persons performing the equivalent functions):


a) all
significant deficiencies and material weakness in the design or operation of
internal controls over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and
report financial data; and


b) any fraud,
whether or not material, that involves management or other employees who have a
significant role in the registrant’s internal control over financial
reporting.




Date:
      February 15, 2010
                          /s/
      Yongqiang WangYongqiang
      WangTitle:
      Chief Financial
Officer